financetom
Business
financetom
/
Business
/
Tesla's First-Quarter Deliveries to Take Further Hit From Softness in China, Deutsche Bank Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla's First-Quarter Deliveries to Take Further Hit From Softness in China, Deutsche Bank Says
Mar 28, 2024 10:23 AM

12:45 PM EDT, 03/28/2024 (MT Newswires) -- Deutsche Bank on Thursday lowered its Tesla (TSLA) delivery estimates for the second time in less than three weeks, citing weaker-than-expected sales in China and the electric vehicle maker's plan to cut production in the region.

The brokerage cut its first-quarter delivery outlook to 414,000 units from 427,000 vehicles due to lower sales in China in the last few weeks of March. Analysts surveyed by Visible Alpha are modeling deliveries of 454,100 units for the first quarter.

Deutsche Bank's full-year estimate was reduced to 1.9 million deliveries from 1.96 million units, now representing mid-single digit growth versus a high-single-digit increase previously expected, Deutsche Bank said in a note emailed Thursday. The consensus on Visible Alpha is 2.03 million units.

"We continue to see pressure on margins and earnings, as the company already announced deep price cuts in both China and Europe earlier in the quarter, and made further moderate price adjustments in February to incentivize vehicle purchases," Deutsche Bank analyst Emmanuel Rosner said.

Rosner previously cut Tesla's estimates on March 11. Tesla's share price has lost nearly 29% so far this year amid a slowdown in the EV market.

Tesla has announced price increases in the US and China effective in April. However, the move appears "as an attempt to boost sales in March, rather than a sign of solid demand," Rosner said Thursday.

Price: 177.43, Change: -2.40, Percent Change: -1.34

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved